First Relief
Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief. 510(k) K212859, from Dyansys, Inc. (San Mateo, CA). Product code NHI, class 2.
As of Nov 20, 2026, K212859 is an FDA 510(k) held by Dyansys, Inc., substantially equivalent on Dec 20, 2021 after 103 days, with no recalls tied to it in FDA's recall database.
- Review time: 103 days
- Recalls: 0
The First Relief is a percutaneous electrical nerve stimulator (PENS) system indicated for multiple treatments up to 56 days for symptomatic relief of chronic, intractable pain from diabetic peripheral neuropathy.
- SPRINT PNS SystemK202660 · Spr Therapeutics, Inc. · Jan 22, 2021
- SPRINT Peripheral Nerve Stimulation System, Extensa, SPRINT Peripheral Nerve Stimulation System, Endura, SPRINT…K181422 · Spr Therapeutics, Inc. · Jul 31, 2018
- Sprint System, Single Procedure Kit, Sprint System with Pad II, Single Procedure Kit, Sprint System, Multi-Procedure…K170902 · Spr Therapeutics, LLC · Jun 26, 2017
- Smartpatch PNS MicroLead and Accessories, Smartpatch PNS Stimulator, Pads, and Accessories, Smartpatch PNS MicroLead…K161154 · Spr Therapeutics, LLC · Jul 23, 2016
- First Relief v1K202940 · Dyansys, Inc. · Dec 29, 2020
- SPRINT Peripheral Nerve Stimulation (PNS) SystemK223306 · Spr Therapeutics, Inc. · Jan 25, 2023
- Primary ReliefK221425 · Dyansys, Inc. · Sep 13, 2022
- ANSiStim-PPK220397 · Dyansys, Inc. · May 12, 2022
- Primary ReliefK213188 · Dyansys, Inc. · Jan 31, 2022
- SPRINT PNS SystemK211801 · Spr Therapeutics, Inc. · Oct 13, 2021
- SPRINT PNS SystemK202660 · Spr Therapeutics, Inc. · Jan 22, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 8, 2021
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5890
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files